Grantham, Mayo, Van Otterloo & Co (GMO)’s New York Times NYT Stock Holding History
Bought
Maintained
Sold
Other funds holding NYT
LP
DCP
Grantham, Mayo, Van Otterloo & Co (GMO)'s NYT Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its New York Times (NYT) stake by 2.2% in Q2 2026, buying an estimated $686K and bringing the position to 405,465 shares worth $28.4M. The position accounts for 0.06% of the portfolio, ranked #141.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NYT in Q3 2017 and has held it in 18 quarters since. The position peaked at $63.7M in Q2 2025. 627 funds tracked by Wall St. Rank hold NYT as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 405,465 shares of New York Times worth $28.4M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 8,898 New York Times shares in Q2 2026, an estimated $686K.
- New York Times made up 0.06% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #141 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in New York Times in Q3 2017 and has held it in 18 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s New York Times position peaked at $63.7M in Q2 2025.
- 627 funds tracked by Wall St. Rank held New York Times as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.